Inventor
PIERCE DANIEL W
US13 patents
⚠️ This page may combine multiple inventors who share the name “PIERCE DANIEL W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CELGENE CORP
6 patentsUS10357489B2Jul 23, 2019
Antiproliferative compounds and methods of use thereof
CELGENE CORP20 citations92
US11185543B2Nov 30, 2021
Antiproliferative compounds and methods of use thereof
CELGENE CORP5 citations82
US12053466B2Aug 6, 2024
Antiproliferative compounds and bispecific antibody against BCMA and CD3 for combined use
CELGENE CORP0 citations61
US11439637B2Sep 13, 2022
Antiproliferative compounds and bispecific antibody against BCMA and CD3 for combined use
CELGENE CORP0 citations61
US12029738B2Jul 9, 2024
Antiproliferative compounds and methods of use thereof
CELGENE CORP0 citations59
US12090147B2Sep 17, 2024
Combination therapy with 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
CELGENE CORP0 citations53
ABRAXIS BIOSCIENCE LLC
5 patentsUS10900951B1Jan 26, 2021
Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel
ABRAXIS BIOSCIENCE LLC6 citations82
US10705070B1Jul 7, 2020
Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug
ABRAXIS BIOSCIENCE LLC8 citations82
US10527604B1Jan 7, 2020
Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel
ABRAXIS BIOSCIENCE LLC10 citations82
US12061183B2Aug 13, 2024
Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug
ABRAXIS BIOSCIENCE LLC2 citations71
US11320416B1May 3, 2022
Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug
ABRAXIS BIOSCIENCE LLC4 citations71